Harmony Biosciences Holdings, Inc.
HRMY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802665
In the last 90 days, Harmony Biosciences Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $1.97B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Harmony Biosciences Holdings, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 242 | 4 | 218 | −20 |
| Shares | 51.4M | 199.2K | 51.3M | +118.7K (+0.2%) |
| Value | $2.81B | $10.8M | $1.68B | −$1.12B (−40.2%) |
4 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (31)
Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (51)
Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (4)
Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Rothschild & Co Asset Management US Inc. | 165,088 | $9.10M |
| Comerica Bank | 17,826 | $874.0K |
| Sheets Smith Investment Management | 11,367 | $544.1K |
| Heritage Wealth Management, LLC | 4,880 | $268.9K |